A. Natsios

Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease.

G. Fragulidis, A. Vezakis, A. Polydorou, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Su1858 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Ulcerative Colitis Patients: Results from the Evolve Study

M. Silverberg, B. Bressler, M. Walshe, 2019, Gastroenterology.

638 Clinical Effectiveness of First-Line Anti-TNF Therapies and Second-Line Anti-TNF Therapy Post-Vedolizumab Discontinuation in Patients With Ulcerative Colitis or Crohn's Disease

U. Kopylov, B. Bressler, G. Mantzaris, 2019, American Journal of Gastroenterology.